Eli Lilly and Company (NYSE:LLY) Trading Down 4.2% After Analyst Downgrade
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) traded down 4.2% on Wednesday after Morgan Stanley lowered their price target on the stock from $1,146.00 to $1,124.00. Morgan Stanley currently has an overweight rating on the stock. Eli Lilly and Company traded as low as $689.00 and last traded at $695.88. 1,795,788 […]
More Stories
Pumpkin Power: Boost Immunity, Regulate Blood Sugar, and Protect Eye Health
By Ellen Wan Pumpkin is rich in functional ingredients and nutrients and offers many potential health benefits. Both scientific research...
GAMMA Investing LLC Raises Position in Eaton Corporation, PLC (NYSE:ETN)
GAMMA Investing LLC raised its position in Eaton Corporation, PLC (NYSE:ETN – Free Report) by 0.7% during the 1st quarter,...
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...